Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
With a market cap of 2.93B, Apellis Pharmaceuticals(APLS) trades at $22.93. The stock has a price-to-earnings ratio of 77.70.
On 2026-01-29, Apellis Pharmaceuticals(APLS) stock traded between a low of $22.14 and a high of $23.79. Shares are currently priced at $22.93, which is +3.6% above the low and -3.6% below the high.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 5.69M, against a daily average of 3.06M.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $30.60 and a 52-week low of $16.10.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $30.60 and a 52-week low of $16.10.
APLS News
Insiders have been trading these 5 stocks: ((APLS)), ((OLMA)), ((XCUR)), ((IMVT)) and ((LPSN)). Here is a breakdown of their recent trades and their value. Cla...
New insider activity at Apellis Pharmaceuticals ( (APLS) ) has taken place on January 23, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and...
Analyst ratings
64%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.